Market capitalization | $137.71b |
Enterprise Value | $148.49b |
P/E (TTM) P/E ratio | 40.30 |
EV/FCF (TTM) EV/FCF | 52.98 |
EV/Sales (TTM) EV/Sales | 6.94 |
P/S ratio (TTM) P/S ratio | 6.44 |
P/B ratio (TTM) P/B ratio | 6.97 |
Dividend yield | 0.84% |
Last dividend (FY23) | $3.05 |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
33 Analysts have issued a Stryker forecast:
33 Analysts have issued a Stryker forecast:
Dec '23 | |
Current assets | 12,518 12,518 |
Fixed assets | 27,394 27,394 |
Total Assets | 39,912 39,912 |
Dec '23 | |
Equity | 18,593 18,593 |
Debt capital | 21,319 21,319 |
Total Capital | 39,912 39,912 |
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
Head office | United States |
CEO | Kevin Lobo |
Employees | 52,000 |
Founded | 1941 |
Website | www.stryker.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.